CLINICAL TRIALS PROFILE FOR DANICAMTIV
✉ Email this page to a colleague
Clinical Trials for danicamtiv
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT04572893 ↗ | Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants | Recruiting | MyoKardia, Inc. | Phase 2 | The purpose of this Phase 2a study is to establish safety and preliminary efficacy of treatment with danicamtiv in patients with primary dilated cardiomyopathy (DCM) due to MYH7 or TTN variants . |
NCT05162222 ↗ | A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to evaluate the effects of co-administration of itraconazole or diltiazem on the single-dose pharmacokinetics of danicamtiv in healthy participants. |
NCT05806359 ↗ | A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to assess the safety, tolerability, and single-dose pharmacokinetics of danicamtiv in healthy Japanese and Caucasian participants. |
NCT05952089 ↗ | A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure | Completed | Bristol-Myers Squibb | Phase 1 | The purpose of this study is assess the effect of danicamtiv, as an inducer on the drug levels of midazolam in participants with heart failure with reduced ejection fraction (HFrEF). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for danicamtiv
Condition Name
Clinical Trial Locations for danicamtiv
Trials by Country
Clinical Trial Progress for danicamtiv
Clinical Trial Phase
Clinical Trial Sponsors for danicamtiv
Sponsor Name